Effective electrochemical n-type doping of ZnO thin films for optoelectronic window applications

[EN] An effective n-type doping of ZnO thin films electrochemically synthetized was achieved by varying the chloride ion concentration in the starting electrolyte. The ratio between chloride and zinc cations was varied between 0 and 2 while the zinc concentration in the solution was kept constant. When the concentration of chloride in the bath increases an effective n-type doping of ZnO films takes place. n-type doping is evidenced by the rise of donors concentration, obtained from Mott-Schottky measurements, as well as from the blueshift observed in the optical gap owing to the Burstein-Moss effect.This work was supported by Spanish Government through MCINN grant MAT2009-14625-C03-03 and European Commission through NanoCIS project FP7-PEOPLE-2010-IRSES (ref. 269279).Cembrero Coca, P.; Mollar García, MA.; Singh, K.; Marí Soucase, B. (2013). Effective electrochemical n-type doping of ZnO thin films for optoelectronic window applications. Journal of Solid State Electrochemistry. 2(7):Q108-Q112. https://doi.org/10.1149/2.023307jssSQ108Q11227Guill�n-Santiago, A., de la L. Olvera, M., Maldonado, A., Asomoza, R., & Acosta, D. R. (2004). Electrical, structural and morphological properties of chemically sprayed F-doped ZnO films: effect of the ageing-time of the starting solution, solvent and substrate temperature. physica status solidi (a), 201(5), 952-959. doi:10.1002/pssa.200306727Oba, F., Choi, M., Togo, A., & Tanaka, I. (2011). Point defects in ZnO: an approach from first principles. Science and Technology of Advanced Materials, 12(3), 034302. doi:10.1088/1468-6996/12/3/034302Oh, B.-Y., Jeong, M.-C., Lee, W., & Myoung, J.-M. (2005). Properties of transparent conductive ZnO:Al films prepared by co-sputtering. Journal of Crystal Growth, 274(3-4), 453-457. doi:10.1016/j.jcrysgro.2004.10.026Manouni, A. E., Manjón, F. J., Mollar, M., Marí, B., Gómez, R., López, M. C., & Ramos-Barrado, J. R. (2006). Effect of aluminium doping on zinc oxide thin films grown by spray pyrolysis. Superlattices and Microstructures, 39(1-4), 185-192. doi:10.1016/j.spmi.2005.08.041Kato, H., Sano, M., Miyamoto, K., & Yao, T. (2002). Growth and characterization of Ga-doped ZnO layers on a-plane sapphire substrates grown by molecular beam epitaxy. Journal of Crystal Growth, 237-239, 538-543. doi:10.1016/s0022-0248(01)01972-8Ye, J. D., Gu, S. L., Zhu, S. M., Liu, S. M., Zheng, Y. D., Zhang, R., & Shi, Y. (2005). Fermi-level band filling and band-gap renormalization in Ga-doped ZnO. Applied Physics Letters, 86(19), 192111. doi:10.1063/1.1928322Morinaga, Y., Sakuragi, K., Fujimura, N., & Ito, T. (1997). Effect of Ce doping on the growth of ZnO thin films. Journal of Crystal Growth, 174(1-4), 691-695. doi:10.1016/s0022-0248(97)00045-6Castañeda, L., García-Valenzuela, A., Zironi, E. P., Cañetas-Ortega, J., Terrones, M., & Maldonado, A. (2006). Formation of indium-doped zinc oxide thin films using chemical spray techniques: The importance of acetic acid content in the aerosol solution and the substrate temperature for enhancing electrical transport. Thin Solid Films, 503(1-2), 212-218. doi:10.1016/j.tsf.2005.12.263Marí, B., Sahal, M., Mollar, M. A., Cerqueira, F. M., & Samantilleke, A. P. (2012). p-Type behaviour of electrodeposited ZnO:Cu films. Journal of Solid State Electrochemistry, 16(6), 2261-2265. doi:10.1007/s10008-011-1635-xHu, J., & Gordon, R. G. (1991). Textured fluorine-doped ZnO films by atmospheric pressure chemical vapor deposition and their use in amorphous silicon solar cells. Solar Cells, 30(1-4), 437-450. doi:10.1016/0379-6787(91)90076-2Xu, H. Y., Liu, Y. C., Mu, R., Shao, C. L., Lu, Y. M., Shen, D. Z., & Fan, X. W. (2005). F-doping effects on electrical and optical properties of ZnO nanocrystalline films. Applied Physics Letters, 86(12), 123107. doi:10.1063/1.1884256Cui, J. B., Soo, Y. C., Chen, T. P., & Gibson, U. J. (2008). Low-Temperature Growth and Characterization of Cl-Doped ZnO Nanowire Arrays. The Journal of Physical Chemistry C, 112(12), 4475-4479. doi:10.1021/jp710855zTchelidze, T., Chikoidze, E., Gorochov, O., & Galtier, P. (2007). Perspectives of chlorine doping of ZnO. Thin Solid Films, 515(24), 8744-8747. doi:10.1016/j.tsf.2007.04.003Chikoidze, E., Nolan, M., Modreanu, M., Sallet, V., & Galtier, P. (2008). Effect of chlorine doping on electrical and optical properties of ZnO thin films. Thin Solid Films, 516(22), 8146-8149. doi:10.1016/j.tsf.2008.04.076Rousset, J., Saucedo, E., & Lincot, D. (2009). Extrinsic Doping of Electrodeposited Zinc Oxide Films by Chlorine for Transparent Conductive Oxide Applications. Chemistry of Materials, 21(3), 534-540. doi:10.1021/cm802765cGordon, R. G. (2000). Criteria for Choosing Transparent Conductors. MRS Bulletin, 25(8), 52-57. doi:10.1557/mrs2000.151Yi, G.-C., Wang, C., & Park, W. I. (2005). ZnO nanorods: synthesis, characterization and applications. Semiconductor Science and Technology, 20(4), S22-S34. doi:10.1088/0268-1242/20/4/003Huang, M. H., Wu, Y., Feick, H., Tran, N., Weber, E., & Yang, P. (2001). Catalytic Growth of Zinc Oxide Nanowires by Vapor Transport. Advanced Materials, 13(2), 113-116. doi:10.1002/1521-4095(200101)13:23.0.co;2-hWang, X., Summers, C. J., & Wang, Z. L. (2004). Large-Scale Hexagonal-Patterned Growth of Aligned ZnO Nanorods for Nano-optoelectronics and Nanosensor Arrays. Nano Letters, 4(3), 423-426. doi:10.1021/nl035102cPark, W. I., Kim, D. H., Jung, S.-W., & Yi, G.-C. (2002). Metalorganic vapor-phase epitaxial growth of vertically well-aligned ZnO nanorods. Applied Physics Letters, 80(22), 4232-4234. doi:10.1063/1.1482800Davidová, M., Nachtigallová, D., Bulánek, R., & Nachtigall, P. (2003). Characterization of the Cu+Sites in High-Silica Zeolites Interacting with the CO Molecule:  Combined Computational and Experimental Study. The Journal of Physical Chemistry B, 107(10), 2327-2332. doi:10.1021/jp026989oBludský, O., Nachtigall, P., Čičmanec, P., Knotek, P., & Bulánek, R. (2005). Characterization of the Cu+ sites in MFI zeolites: combined computational and experimental study. Catalysis Today, 100(3-4), 385-389. doi:10.1016/j.cattod.2004.09.070Lévy-Clément, C., Tena-Zaera, R., Ryan, M. A., Katty, A., & Hodes, G. (2005). CdSe-Sensitized p-CuSCN/Nanowire n-ZnO Heterojunctions. Advanced Materials, 17(12), 1512-1515. doi:10.1002/adma.200401848Könenkamp, R., Word, R. C., & Godinez, M. (2005). Ultraviolet Electroluminescence from ZnO/Polymer Heterojunction Light-Emitting Diodes. Nano Letters, 5(10), 2005-2008. doi:10.1021/nl051501rMentzen, B. F., & Bergeret, G. (2007). Crystallographic Determination of the Positions of the Copper Cations in Zeolite MFI. The Journal of Physical Chemistry C, 111(34), 12512-12516. doi:10.1021/jp075452dIzaki, M., & Omi, T. (1996). Transparent zinc oxide films prepared by electrochemical reaction. Applied Physics Letters, 68(17), 2439-2440. doi:10.1063/1.116160Gu, Z. H. (1999). Electrochemical Deposition of ZnO Thin Films on Tin-Coated Glasses. Journal of The Electrochemical Society, 146(1), 156. doi:10.1149/1.1391579Peulon, S., & Lincot, D. (1996). Cathodic electrodeposition from aqueous solution of dense or open-structured zinc oxide films. Advanced Materials, 8(2), 166-170. doi:10.1002/adma.19960080216Elias, J., Tena-Zaera, R., & Lévy-Clément, C. (2007). Electrodeposition of ZnO nanowires with controlled dimensions for photovoltaic applications: Role of buffer layer. Thin Solid Films, 515(24), 8553-8557. doi:10.1016/j.tsf.2007.04.027Pauporté, T., & Lincot, D. (2001). Hydrogen peroxide oxygen precursor for zinc oxide electrodeposition II—Mechanistic aspects. Journal of Electroanalytical Chemistry, 517(1-2), 54-62. doi:10.1016/s0022-0728(01)00674-xElias, J., Tena-Zaera, R., & Lévy-Clément, C. (2008). Effect of the Chemical Nature of the Anions on the Electrodeposition of ZnO Nanowire Arrays. The Journal of Physical Chemistry C, 112(15), 5736-5741. doi:10.1021/jp7120092Marí, B., Tortosa, M., Mollar, M., Boscà, J. V., & Cui, H. N. (2010). Electrodeposited ZnCdO thin films as conducting optical layer for optoelectronic devices. Optical Materials, 32(11), 1423-1426. doi:10.1016/j.optmat.2010.05.009Cembrero, J., Busquets-Mataix, D., Rayón, E., Pascual, M., Pérez-Puig, M. A., & Marí, B. (2013). Control parameters on the fabrication of ZnO hollow nanocolumns. Materials Science in Semiconductor Processing, 16(1), 211-216. doi:10.1016/j.mssp.2012.04.014Cardon, F., & Gomes, W. P. (1978). On the determination of the flat-band potential of a semiconductor in contact with a metal or an electrolyte from the Mott-Schottky plot. Journal of Physics D: Applied Physics, 11(4), L63-L67. doi:10.1088/0022-3727/11/4/003Windisch, C. F., & Exarhos, G. J. (2000). Mott–Schottky analysis of thin ZnO films. Journal of Vacuum Science & Technology A: Vacuum, Surfaces, and Films, 18(4), 1677-1680. doi:10.1116/1.582406Mora-Seró, I., Fabregat-Santiago, F., Denier, B., Bisquert, J., Tena-Zaera, R., Elias, J., & Lévy-Clément, C. (2006). Determination of carrier density of ZnO nanowires by electrochemical techniques. Applied Physics Letters, 89(20), 203117. doi:10.1063/1.2390667Roth, A. P., Webb, J. B., & Williams, D. F. (1982). Band-gap narrowing in heavily defect-doped ZnO. Physical Review B, 25(12), 7836-7839. doi:10.1103/physrevb.25.7836Kim, C. E., Moon, P., Kim, S., Myoung, J.-M., Jang, H. W., Bang, J., & Yun, I. (2010). Effect of carrier concentration on optical bandgap shift in ZnO:Ga thin films. Thin Solid Films, 518(22), 6304-6307. doi:10.1016/j.tsf.2010.03.042Baer, W. S. (1967). Faraday Rotation in ZnO: Determination of the Electron Effective Mass. Physical Review, 154(3), 785-789. doi:10.1103/physrev.154.785Aghamalyan, N. R., Kafadaryan, E. A., Hovsepyan, R. K., & Petrosyan, S. I. (2004). Absorption and reflection analysis of transparent conductive Ga-doped ZnO films. Semiconductor Science and Technology, 20(1), 80-85. doi:10.1088/0268-1242/20/1/01

Informe sobre la evolución de la asistencia psiquiátrica en la provincia de Alicante (1981-1988).

Hasta el año 1981, la asistencia psiquiátrica en la provincia, se reduce a un único dispositivo asistencial de características manicomiales y asilares: el Sanatorio Psiquiátrico Provincial que depende económica y administrativamente de la Diputación Provincial. A título orientativo, señalamos algunos datos que dan cuenta de su estructura y funcionamiento: Según el censo de primero de enero de ese año, eran 620 las camas ocupadas. Escasa dotación de personal asistencial (dos médicos psiquiatras a dedicación parcial)

Informe sobre la evolución de la asistencia psiquiátrica en la provincia de Alicante (1981-1988).

Hasta el año 1981, la asistencia psiquiátrica en la provincia, se reduce a un único dispositivo asistencial de características manicomiales y asilares: el Sanatorio Psiquiátrico Provincial que depende económica y administrativamente de la Diputación Provincial. A título orientativo, señalamos algunos datos que dan cuenta de su estructura y funcionamiento: Según el censo de primero de enero de ese año, eran 620 las camas ocupadas. Escasa dotación de personal asistencial (dos médicos psiquiatras a dedicación parcial)

Informe sobre la evolución de la asistencia psiquiátrica en la provincia de Alicante (1981-1988).

Hasta el año 1981, la asistencia psiquiátrica en la provincia, se reduce a un único dispositivo asistencial de características manicomiales y asilares: el Sanatorio Psiquiátrico Provincial que depende económica y administrativamente de la Diputación Provincial. A título orientativo, señalamos algunos datos que dan cuenta de su estructura y funcionamiento: Según el censo de primero de enero de ese año, eran 620 las camas ocupadas. Escasa dotación de personal asistencial (dos médicos psiquiatras a dedicación parcial)

Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia

This is an open access article distributed under the Creative Commons Attribution License.-- et al.The aim of this study was to investigate the frequency and mutation status of the immunoglobulin heavy variable chain (IGHV) in a cohort of 224 patients from northwest and central region of Spain diagnosed with chronic lymphocytic leukemia (CLL), and to correlate it with cytogenetic abnormalities, overall survival (OS) and time to first treatment (TTFT). 125 patients had mutated IGHV, while 99 had unmutated IGHV. The most frequently used IGHV family was IGHV3, followed by IGHV1 and IGHV4. The regions IGHV3-30, IGHV1-69, IGHV3-23, and IGHV4-34 were the most commonly used. Only 3.1% of the patients belonged to the subfamily IGHV3-21 and we failed to demonstrate a worse clinical outcome in this subgroup. The IGHV4 family appeared more frequently with mutated pattern, similar to IGHV3-23 and IGHV3-74. By contrast, IGHV1-69 was expressed at a higher frequency in unmutated CLL patients. All the cases from IGHV3-11 and almost all from IGHV5-51 subfamily belonged to the group of unmutated CLL.The study was partially supported by grants from the Spanish Fondo de Investigaciones Sanitarias 02/1041, FIS 09/01382, FIS 09/01543, and PI12/00281; RD12/0036/0069 from Red Tematica de Investigación Cooperativa en Cáncer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF) “Una manera de hacer Europa”; and Caja de Burgos-Banca Cívica. A. Rodrígues was fully supported by an Ayuda Predoctoral FIS de Formación en Investigacion by the Spanish Fondo de Investigaciones Sanitarias. M. Hernandez-Sanchez was partially supported by a grant from the “Fundacion Española de Hematología y Hemoterapia.” Partially supported by grants from “Proyectos de Investigacion Biomédica del SACYL” 106/A/06.Peer Reviewe

Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival

Immunoparesis is the suppression of normal polyclonal immunoglobulins and is present in most patients with newly diagnosed multiple myeloma (MM). The association of immunoparesis at diagnosis, and particularly its recovery along with treatment, with survival in patients ineligible for autologous stem-cell transplantation (ASCT) has not been well established. This retrospective study evaluated the impact of immunoparesis in 431 patients diagnosed with MM, ineligible for ASCT, with a median overall survival of 36 months [95% confidence interval (CI): 31–40]. Immunoparesis was present in 81.2% of patients at diagnosis and was associated with a trend to a worse overall response rate (ORR: 84.8% vs. 74.9%; OR 1.88 (95% CI: 0.97–3.63), shorter progression-free survival (PFS) [22.0 vs. 18.2 months; hazard ratio (HR) 0.775; 95%CI: 0.590–1.018; p = 0.066], and overall survival (OS) (45.9 vs. 34.2 months; HR 0.746; 95% CI: 0.551–1.010; p = 0.057). Twenty-four per cent of patients who had immunoparesis at diagnosis recovered polyclonal immunoglobulins in the follow-up period. Interestingly, these patients had a better ORR (96.3% vs. 68.2%; OR 12.29 (95% CI: 3.77–40.06), PFS (HR 0.703; 95CI%: 0.526–0.941; p = 0.018) and OS (HR 0.678; 95 CI%: 0.503–0.913; p = 0.011) than patients who did not recover it. In summary, restoring a healthy immune system along with first-line treatment in patients with MM, not receiving ASCT, is associated with better outcomes

Primary care referrals of patients with potentially serious diseases to the emergency department or a quick diagnosis unit: a cross-sectional retrospective study.

BACKGROUND: In Spain, primary healthcare (PHC) referrals for diagnostic procedures are subject to long waiting-times, and physicians and patients often use the emergency department (ED) as a shortcut. We aimed to determine whether patients evaluated at a hospital outpatient quick diagnosis unit (QDU) who were referred to ED from 12 PHC centers could have been directly referred to QDU, thus avoiding ED visits. As a secondary objective, we determined the proportion of QDU patients who might have been evaluated in a less rapid, non-QDU setting. METHODS: We carried out a cross-sectional retrospective cohort study of patients with potentially serious conditions attended by the QDU from December 2007 to December 2012. We established 2 groups of patients: 1) patients referred from PHC to QDU (PHC-QDU group) and 2) patients referred from PHC to ED, then to QDU (PHC-ED-QDU group). Two observers assessed the appropriateness/inappropriateness of each referral using a scoring system. The interobserver agreement was assessed by calculating the kappa index. Multivariate logistic regression analysis was performed to identify the factors associated with the dependent variable 'ED referral'. RESULTS: We evaluated 1186 PHC-QDU and 1004 PHC-ED-QDU patients and estimated that 93.1% of PHC-ED-QDU patients might have been directly referred to QDU. In contrast, 96% of PHC-QDU patients were found to be appropriately referred to QDU first. The agreement for PHC-QDU referrals (PHC-QDU group) was rated as excellent (ϰ=0.81), while it was rated as good for PHC-ED referrals (PHC-ED-QDU group) (ϰ=0.75). The mean waiting-time for the first QDU visit was longer in PHC-QDU (4.8 days) than in PHC-ED-QDU (2.6 days) patients (P=.001). On multivariate analysis, anemia (OR 2.87, 95% CI 1.49-4.55, P<.001), rectorrhagia (OR 2.18, 95% CI 1.10-3.77, P=.01) and febrile syndrome (OR 2.53, 95% CI 1.33-4.12, P=.002) were independent factors associated with ED referral. Nearly one-fifth of all QDU patients were found who might have been evaluated in a less rapid, non-QDU setting. CONCLUSIONS: Most PHC-ED-QDU patients might have been directly referred to QDU from PHC, avoiding the inconvenience of the ED visit. A stricter definition of QDU evaluation criteria may be needed to improve and hasten PHC referrals

MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL

This is an Open Access article distributed under the terms of the Creative Commons Attribution License.-- et al.[Background]: MicroRNAs are known to inhibit gene expression by binding to the 3'UTR of the target transcript. Downregulation of miR-223 has been recently reported to have prognostic significance in CLL. However, there is no evidence of the pathogenetic mechanism of this miRNA in CLL patients. [Methods]: By applying next-generation sequencing techniques we have detected a common polymorphism (rs2307842), in 24% of CLL patients, which disrupts the binding site for miR-223 in HSP90B1 3'UTR. We investigated whether miR-223 directly targets HSP90B1 through luciferase assays and ectopic expression of miR-223. Quantitative real-time polymerase chain reaction and western blot were used to determine HSP90B1 expression in CLL patients. The relationship between rs2307842 status, HSP90B1 expression and clinico-biological data were assessed. [Results]: HSP90B1 is a direct target for miR-223 by interaction with the putative miR-223 binding site. The analysis in paired samples (CD19+ fraction cell and non-CD19+ fraction cell) showed that the presence of rs2307842 and IGHV unmutated genes determined HSP90B1 overexpression in B lymphocytes from CLL patients. These results were confirmed at the protein level by western blot. Of note, HSP90B1 overexpression was independently predictive of shorter time to the first therapy in CLL patients. By contrast, the presence of rs2307842 was not related to the outcome. [Conclusions]: HSP90B1 is a direct target gene of miR-223. Our results provide a plausible explanation of why CLL patients harboring miR-223 downregulation are associated with a poor outcome, pointing out HSP90B1 as a new pathogenic mechanism in CLL and a promising therapeutic target.This work was partially supported by grants from the Spanish Fondo de Investigaciones Sanitarias FIS 09/01543 and PI12/00281, Proyectos de Investigación del SACYL 355/A/09, COST Action EuGESMA (BM0801), Fundación Manuel Solórzano, Obra Social Banca Cívica (Caja Burgos), Fundación Española de Hematología y Hemoterapia (FEHH) and by a grant (RD12/0036/0069) from the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF) “Una manera de hacer Europa” (Innocampus). The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement n°306242-NGS-PTL. MHS is fully supported by an Ayuda predoctoral de la Junta de Castilla y Leon by the Fondo Social Europeo. ME Sarasquete is supported by Contrato Miguel Servet (CP13/00080).Peer Reviewe